Amedisys Inc, a multi-regional healthcare provider, has recently settled with the DOJ and seen a significant decline in its stock price over the past five years, but remains a key player in the healthcare sector with a strong network of subsidiaries.

Amedisys Inc. is facing significant challenges, including a 46.95% decline in share value and a legal hurdle with the Department of Justice, highlighting the risks inherent in the healthcare sector.